The 6 bullish and 1 somewhat bullish analyst ratings for Rocket Pharmaceuticals indicate a positive outlook for the stock. The average price target of $57.0, which is up 6.2% from the previous average, suggests that analysts believe the stock has potential for growth in the short term. This positive sentiment is likely to have a positive impact on the stock price.